文献速递肝病消化道肿瘤与早癌

CD97通过传统G蛋白偶联受体介导的信号通路促进肝细胞癌的肿瘤侵袭性

CD97 Promotes Tumor Aggressiveness Through the Traditional G Protein-Coupled Receptor-Mediated Signaling in Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2018-09-22

本研究探讨CD97在肝细胞癌(HCC)中的作用,发现CD97在HCC中上调且与肿瘤转移正相关,体外促进细胞迁移和侵袭,小鼠模型中过表达CD97加速肺转移。机制上CD97与GRK6协同介导GPCR脱敏和内化,下调GRK6抑制CD97内化并促进其表达,CD97与GRK6的调控互动刺激下游基质金属蛋白酶2/9分泌,进而促进HCC转移。结论支持CD97作为HCC潜在预后标志物和治疗靶点。

要点

  • CD97在肝细胞癌中上调并与肿瘤转移正相关。
  • CD97体外促进细胞迁移和侵袭,小鼠体内过表达加速肺转移。
  • CD97与GRK6协同调控GPCR内化并刺激MMP2/9分泌促进转移。

核心结论

  • CD97可作为肝细胞癌的有效潜在预后标志物和治疗靶点。

研究设计与样本

  • 本研究为实验研究,包含体外细胞功能实验和体内小鼠模型,具体样本量原文未报告。

主要发现

  • CD97在肝细胞癌中上调与肿瘤转移正相关。
  • CD97体外促进细胞迁移和侵袭。
  • 小鼠模型中过表达CD97导致肺转移加速。
  • CD97与GRK6协同介导GPCR脱敏和内化,下调GRK6抑制CD97内化并促进CD97表达。
  • CD97与GRK6的调控互动刺激下游基质金属蛋白酶2/9分泌,进而促进肝细胞癌转移。

临床怎么用

  • 作者认为CD97可作为肝细胞癌的有效潜在预后标志物和治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cluster of differentiation 97 (CD97) is a member of the epidermal growth factor seven-transmembrane family belonging to the class B G protein-coupled receptors (GPCRs). The protein affects tumor aggressiveness through its cellular ligand CD55 stimulation and exhibits adhesive properties. Studies have demonstrated the involvement of CD97 in dedifferentiation, migration, invasiveness, and metastasis of tumors. However, little information is currently available on the specific role of CD97 in hepatocellular carcinoma (HCC). Here, we have shown that CD97 up-regulation in HCCs is positively correlated with tumor metastasis. Functionally, CD97 promoted cell migration and invasion in vitro. In an in vivo mouse model, overexpression of CD97 in HCC cells led to accelerated lung metastasis. Mechanistically, CD97 cooperated with the altered regulator, GPCR kinase 6 (GRK6), to mediate GPCR desensitization and internalization. Down-regulation of GRK6 suppressed CD97 internalization and promoted CD97 expression. Integrated regulatory interactions between CD97 and GRK6 stimulated downstream matrix metalloproteinase 2/9 secretion and, consequently, HCC metastasis. Conclusion: Our collective findings support the utility of CD97 as an effective potential prognosticator and therapeutic target for HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yin Y, Xu X, Tang J, et al. CD97 Promotes Tumor Aggressiveness Through the Traditional G Protein-Coupled Receptor-Mediated Signaling in Hepatocellular Carcinoma. Hepatology. 2018. PMID: 29704239. doi:10.1002/hep.30068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。